Discontinued — last reported Q3 '25
Equity
Redeemable NCI
GE HealthCare Technologies Redeemable NCI increased by 4.3% to $218.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3.3%, from $211.00M to $218.00M. Over 5 years (FY 2020 to FY 2025), Redeemable NCI shows relatively stable performance with a -1.3% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryLiquidity
SignalLower is better
VolatilityStable
First reportedQ4 2015
Last reportedQ3 2025
How to read this metric
An increase indicates a potential future cash outflow obligation, which could impact liquidity.
Detailed definition
This represents equity interests in subsidiaries held by third parties that have redemption features, allowing the holde...
Peer comparison
Common in companies with complex joint ventures or partially owned subsidiaries.
Metric ID:
redeemable_noncontrolling_interestsHistorical Data
18 periods
| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $220.00M | $229.00M | $220.00M | $198.00M | $230.00M | $201.00M | $209.00M | $161.00M | $165.00M | $177.00M | $177.00M | $177.00M | $188.00M | $211.00M | $220.00M | $204.00M | $209.00M | $218.00M |
| QoQ Change | — | +4.1% | -3.9% | -10.0% | +16.2% | -12.6% | +4.0% | -23.0% | +2.5% | +7.3% | +0.0% | +0.0% | +6.2% | +12.2% | +4.3% | -7.3% | +2.5% | +4.3% |
| YoY Change | — | — | — | — | +4.5% | -12.2% | -5.0% | -18.7% | -28.3% | -11.9% | -15.3% | +9.9% | +13.9% | +19.2% | +24.3% | +15.3% | +11.2% | +3.3% |
Range$161.00M – $230.00M
CAGR-0.2%
Avg YoY Growth+0.7%
Median YoY Growth+3.9%
Current Streak2 quarters growth
Redeemable NCI at Other Companies
Frequently Asked Questions
- What is GE HealthCare Technologies's redeemable nci?
- GE HealthCare Technologies (GEHC) reported redeemable nci of $218.00M in Q1 2026.
- How has GE HealthCare Technologies's redeemable nci changed year-over-year?
- GE HealthCare Technologies's redeemable nci increased by 3.3% year-over-year, from $211.00M to $218.00M.
- What is the long-term trend for GE HealthCare Technologies's redeemable nci?
- Over 5 years (2020 to 2025), GE HealthCare Technologies's redeemable nci has grown at a -1.3% compound annual growth rate (CAGR), from $223.00M to $209.00M.
- What does redeemable nci mean?
- Equity held by others in a subsidiary that the company may be required to repurchase.